1995
DOI: 10.1016/s0022-3476(95)70198-2
|View full text |Cite
|
Sign up to set email alerts
|

Vertical transmission of human immunodeficiency virus type 1: Autologous neutralizing antibody, virus load, and virus phenotype

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
27
0
1

Year Published

1996
1996
2012
2012

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 50 publications
(30 citation statements)
references
References 43 publications
2
27
0
1
Order By: Relevance
“…Possible selective pressures influencing perinatal HIV-1 transmission include maternal viral phenotype, tropism, coreceptor usage, maternal neutralizing antibody, and/or other immune pressures (19,24,27,38). In the present study, low maternal CD4 counts and low rates of HIV-1 env gene diversity were observed primarily in mothers transmitting major env variants to their infants in utero.…”
Section: Discussionmentioning
confidence: 99%
“…Possible selective pressures influencing perinatal HIV-1 transmission include maternal viral phenotype, tropism, coreceptor usage, maternal neutralizing antibody, and/or other immune pressures (19,24,27,38). In the present study, low maternal CD4 counts and low rates of HIV-1 env gene diversity were observed primarily in mothers transmitting major env variants to their infants in utero.…”
Section: Discussionmentioning
confidence: 99%
“…However, the results of studies of the effect of maternal NAb on transmission have reached divergent conclusions as to whether NAbs are important during all stages of mother-to-child transmission (in utero, intrapartum, and breastfeeding); for example, one study suggested a protective effect of NAb only for intrapartum transmission (Barin et al 2006;Samleerat et al 2009), whereas two others suggest NAb protection only in utero transmission (Dickover et al 2006). Moreover, some studies have reported no association of maternal NAbs and infant infection (Husson et al 1995;Hengel et al 1998). These divergent findings could reflect methodological differences, such as the relative timing of the NAb and viruses studied, which is critical given the rapid evolution of both virus and antibody responses (Burton et al 2005), whether the study examined autologous or heterologous responses and the assays used, as well as the sample size of the study, which in the earliest studies was typically small.…”
Section: Because Effective Protection Afforded By Most Vaccines Corrementioning
confidence: 99%
“…Indeed, some studies have shown that mothers who transmitted to their infants had lower titers of NAb against autologous viruses than did nontransmitting mothers (13,27,30,62), although not all studies have shown this association (18,20,23). Some of the differences in these findings could reflect inconsistencies in sampling viruses and antibodies near the window of transmission.…”
mentioning
confidence: 99%